Limited coverage drugs – cyproterone

Generic name Strength Form


100 mg/1 mL ampoule


50 mg tablet

Special Authority criteria

Approval period

Indication of need to reduce aggressive sexual drive


Practitioner exemptions

  • None

Special notes

  • Criteria applicable for all plans including Plan G
  • For any cancer related condition, please contact the British Columbia Cancer Agency at 604-877-6098 Ext. 4610

Special Authority request form(s)